Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[New therapeutic weapons in stage IV melanoma].
Tzika E, Moura B, Romano E, Michielin O. Tzika E, et al. Among authors: michielin o. Rev Med Suisse. 2013 May 22;9(387):1095-8. Rev Med Suisse. 2013. PMID: 23757918 Review. French.
[Present chemoprevention and future vision].
Filges I, Zaman K, Michielin O, Vulliémoz D, Perey L, Stupp R. Filges I, et al. Among authors: michielin o. Rev Med Suisse. 2005 May 18;1(20):1343-6, 1349. Rev Med Suisse. 2005. PMID: 15991626 Review. French.
Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
Berthod G, Lazor R, Letovanec I, Romano E, Noirez L, Mazza Stalder J, Speiser DE, Peters S, Michielin O. Berthod G, et al. Among authors: michielin o. J Clin Oncol. 2012 Jun 10;30(17):e156-9. doi: 10.1200/JCO.2011.39.3298. Epub 2012 Apr 30. J Clin Oncol. 2012. PMID: 22547608 No abstract available.
Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
Romano E, Pradervand S, Paillusson A, Weber J, Harshman K, Muehlethaler K, Speiser D, Peters S, Rimoldi D, Michielin O. Romano E, et al. Among authors: michielin o. Clin Cancer Res. 2013 Oct 15;19(20):5749-57. doi: 10.1158/1078-0432.CCR-13-0661. Epub 2013 Aug 15. Clin Cancer Res. 2013. PMID: 23948972
Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.
Kvistborg P, Philips D, Kelderman S, Hageman L, Ottensmeier C, Joseph-Pietras D, Welters MJ, van der Burg S, Kapiteijn E, Michielin O, Romano E, Linnemann C, Speiser D, Blank C, Haanen JB, Schumacher TN. Kvistborg P, et al. Among authors: michielin o. Sci Transl Med. 2014 Sep 17;6(254):254ra128. doi: 10.1126/scitranslmed.3008918. Sci Transl Med. 2014. PMID: 25232180
293 results